
MiniMed Group, Inc. Common Stock (MMED) Stock Overview
Explore MiniMed Group, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
MiniMed Group, Inc. Common Stock (MMED)
Key Financials
Key Financials
Market Cap
5.5B
P/E Ratio
-17.71
EPS (TTM)
$-0.78
ROE
-0.14%
MMED Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of MiniMed Group, Inc. Common Stock (NASDAQ: MMED) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, MiniMed Group, Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MMED on the NASDAQ shows an RSI of 72.22, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $14.71 for the NASDAQ listing.
Key metrics behind MiniMed Group, Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -17.71 and a market capitalization of 5.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MMED on the NASDAQ.